Liver Pathology in Infantile Mitochondrial DNA Depletion Syndrome

被引:8
|
作者
Hazard, Florette K. [1 ]
Ficicioglu, Can H. [2 ]
Ganesh, Jaya [2 ]
Ruchelli, Eduardo D. [3 ]
机构
[1] Stanford Univ, Sch Med, Dept Pathol & Pediat, Stanford, CA 94305 USA
[2] Childrens Hosp Philadelphia, Dept Pediat, Div Child Dev Rehabil & Metab Dis, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA
关键词
DNA depletion; liver; metabolic dysfunction; mitochondria; pediatric; BILE-DUCT LOSS; HEPATOCEREBRAL FORM; MUTATIONS; HEPATOPATHIES; HYPOPLASIA; DEFICIENCY; EXPRESSION; PAUCITY; GENE;
D O I
10.2350/12-07-1229-OA.1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Mitochondrial DNA (mtDNA) depletion syndrome is a relatively novel cause of hepatic dysfunction in the pediatric population. It is caused by mutations in either mtDNA or nuclear DNA (nDNA) that result in a quantitative reduction in mtDNA and, in turn, dysfunctional oxidative phosphorylation. In infants, it results in the hepatocerebral phenotype, characterized by hyperbilirubinemia, coagulopathy, lactic acidosis, hypoglycemia, lethargy, encephalopathy, developmental delay, and hypotonia. Three infants diagnosed with mtDNA depletion syndrome at The Children's Hospital of Philadelphia were identified, and their clinical presentation, disease course, and histologic and ultrastructural features of liver samples (pre- and postmortem) were characterized. While a different mutant gene was identified in each child, they all showed clinical evidence of metabolic dysfunction soon after birth and expired by 1 year of age. Steatosis, cholestasis, and cytoplasmic crowding by atypical mitochondria were consistent pathologic liver findings. Other findings included hepatocyte hypereosinophilia, fibrosis, and hemosiderosis. This analysis provides insight into the important clinical signs/symptoms and histopathologic and ultrastructural features of mtDNA depletion syndrome in infants and young children. Knowledge of these characteristics will facilitate early recognition and appropriate treatment of this rare disorder. Additionally, ultrastructural evaluation of liver samples by electron microscopy is an important diagnostic component of hepatic dysfunction caused by metabolic abnormalities. This type of analysis should be routinely employed in the setting of unexplained cholestasis, especially when accompanied by steatosis and hepatocyte hypereosinophilia.
引用
收藏
页码:415 / 424
页数:10
相关论文
共 50 条
  • [41] HISTOPATHOLOGICAL LIVER FINDINGS IN PATIENTS WITH HEPATOCEREBRAL MITOCHONDRIAL DEPLETION SYNDROME WITH DEFINED MOLECULAR BASIS
    Pronicki, Maciej
    Piekutowska-Abramczuk, Dorota
    Rokicki, Dariusz
    Iwanicka-Pronicka, Katarzyna
    Grajkowska, Wieslawa
    POLISH JOURNAL OF PATHOLOGY, 2018, 69 (03) : 292 - 298
  • [42] LIVER PATHOLOGY IN HEPATO-CEREBRAL MITOCHONDRIAL DEPLETION SYNDROMES DUE TO POLG1, DGUOK, OR MPV17 VARIANTS
    Finsterer, Josef
    POLISH JOURNAL OF PATHOLOGY, 2019, 70 (02) : 146 - 147
  • [43] A case of mitochondrial DNA depletion syndrome type 11-expanding the genotype and phenotype
    Rocha, Emanuelle Bianchi da Silva
    Rodrigues, Ketteny de Lima
    Montouro, Laura Alonso Matheus
    Coelho, erica Nogueira
    Kouyoumdjian, Joao Aris
    Kok, Fernando
    Nobrega, Paulo Ribeiro
    Graca, Carla Renata
    Morita, Maria da Penha Ananias
    Estephan, Eduardo de Paula
    NEUROMUSCULAR DISORDERS, 2023, 33 (08) : 692 - 696
  • [44] Two novel SUCLA2 variants cause mitochondrial DNA depletion syndrome, type 5 in two siblings
    Zhang, Xiaohuan
    Zhang, Guo
    Cao, Li
    Zhou, Wenjing
    Tan, Chang
    Ma, Shi
    Yang, Jiyun
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [45] Case report: Two unexpected cases of DGUOK-related mitochondrial DNA depletion syndrome presenting with hyperinsulinemic hypoglycemia
    Guzman, Herodes
    Yazdani, Sahr
    Harmon, Jennifer L.
    Chapman, Kimberly A.
    Vitola, Bernadette
    Pyle, Louise
    Mcknight, Heather
    Sigal, Winnie
    Lord, Katherine
    De Leon, Diva D.
    Merchant, Nadia
    Ganetzky, Rebecca
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [46] Lipopolysaccharide-Induced Mitochondrial DNA Depletion
    Choumar, Amal
    Tarhuni, Arige
    Letteron, Philippe
    Reyl-Desmars, Florence
    Dauhoo, Nismah
    Damasse, Julie
    Vadrot, Nathalie
    Nahon, Pierre
    Moreau, Richard
    Pessayre, Dominique
    Mansouri, Abdellah
    ANTIOXIDANTS & REDOX SIGNALING, 2011, 15 (11) : 2837 - 2854
  • [47] Analysis of Mutant DNA Polymerase γ in Patients With Mitochondrial DNA Depletion
    Taanman, Jan-Willem
    Rahman, Shamima
    Pagnamenta, Alistair T.
    Morris, Andrew A. M.
    Bitner-Glindzicz, Maria
    Wolf, Nicole I.
    Leonard, James V.
    Clayton, Peter T.
    Schapira, Anthony H. V.
    HUMAN MUTATION, 2009, 30 (02) : 248 - 254
  • [48] Mitochondrial DNA depletion causes decreased ROS production and resistance to apoptosis
    Chen, Hulin
    Wang, Junling
    Liu, Zhongrong
    Yang, Huilan
    Zhu, Yingjie
    Zhao, Minling
    Liu, Yan
    Yan, Miaomiao
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 (04) : 1039 - 1046
  • [49] FBXL4-related encephalomyopathic mitochondrial DNA depletion syndrome: A rare cause of hyperammonemia
    Kahraman, Ayca Burcu
    Celik, Halil
    Bagci, Zafer
    Sezer, Abdullah
    Kilic, Mustafa
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2025, 43
  • [50] Hepatocerebral form of mitochondrial DNA depletion syndrome due to mutation in MPV17 gene
    AlSaman, Abdulaziz
    Tomoum, Hoda
    Invernizzi, Federica
    Zeviani, Massimo
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2012, 18 (04) : 285 - 289